Constellation Software Inc. and Topicus.Com Inc. Announce Results for Topicus.com Inc. for the Third Quarter Ended September 30, 2026

(TSXV:TOI) Topicus.com Inc. and Constellation Software Inc. (TSX:CSU) announced financial results for Topicus.com Inc. for the third quarter ended September 30, 2026. Revenue for Q3 2026 increased 15% (5% organic growth) to €445.1 million compared to €387.9 million in Q3 2025. Net income for Q3 2026 was €46.5 million (€0.34 diluted per share), up from a net loss of €120.9 million (€0.94 diluted net loss per share) in Q3 2025. Acquisitions were completed for aggregate cash consideration of €47.1 million, with deferred payments valued at €17.0 million, resulting in total consideration of €64.0 million. Cash flows from operations for Q3 2026 were €47.4 million, a decrease of €1.1 million or 2% from €48.4 million in Q3 2025. Free cash flow available to shareholders (FCFA2S) for Q3 2026 was €18.8 million, down €3.5 million or 16% from €22.3 million in Q3 2025. For the nine months ended September 30, 2026, total revenues were €1,318.0 million, up 18% or €202.5 million from €1,115.5 million in the same period of 2025. Net income for the nine months ended September 30, 2026 was €148.9 million, an increase of €158.2 million from a net loss of €9.3 million in the same period of 2025. Net income per basic and diluted share for the nine months ended September 30, 2026 was €1.11, compared to a net loss of €0.09 per share in the same period of 2025. Cash flows from operations for the nine months ended September 30, 2026 were €315.2 million, up €10.2 million or 3% from €304.9 million in the same period of 2025. FCFA2S for the nine months ended September 30, 2026 was €199.1 million, up €31.7 million or 19% from €167.5 million in the same period of 2025. As of September 30, 2026, current assets included cash of €342,391 thousand, accounts receivable of €192,304 thousand, unbilled revenue of €76,974 thousand, inventories of €8,452 thousand, and other assets of €88,445 thousand, totaling €708,566 thousand. Non-current assets included property and equipment of €29,610 thousand, right of use assets of €87,868 thousand, deferred income taxes of €22,541 thousand, investments in associates of €484,632 thousand, other assets of €18,872 thousand, and intangible assets of €1,223,776 thousand, totaling €1,867,297 thousand. Total assets as of September 30, 2026 were €2,575,863 thousand. Current liabilities as of September 30, 2026 included Topicus Revolving Credit Facility and current portion of Term and other loans of €127,226 thousand, accounts payable and accrued liabilities of €369,509 thousand, deferred revenue of €295,058 thousand, provisions of €3,498 thousand, acquisition holdback payables of €28,052 thousand, lease obligations of €30,845 thousand, and income taxes payable of €36,955 thousand, totaling €891,143 thousand. Non-current liabilities included term and other loans of €352,467 thousand, deferred income taxes of €190,575 thousand, acquisition holdback payables of €49,232 thousand, lease obligations of €59,055 thousand, and other liabilities of €100,335 thousand, totaling €751,663 thousand. Total liabilities as of September 30, 2026 were €1,642,806 thousand. Shareholders' equity as of September 30, 2026 included capital stock of €39,412 thousand, accumulated other comprehensive income of €129,909 thousand, retained earnings of €406,793 thousand, and non-controlling interests of €356,943 thousand, totaling €933,057 thousand. For Q3 2026, license revenue was €11,460 thousand, professional services revenue was €94,859 thousand, hardware and other revenue was €13,018 thousand, and maintenance and other recurring revenue was €325,755 thousand. For the nine months ended September 30, 2026, license revenue was €32,832 thousand, professional services revenue was €291,926 thousand, hardware and other revenue was €34,112 thousand, and maintenance and other recurring revenue was €959,162 thousand. Staff expenses for Q3 2026 were €230,040 thousand and for the nine months ended September 30, 2026 were €704,956 thousand. Hardware expenses for Q3 2026 were €8,099 thousand and for the nine months ended September 30, 2026 were €19,286 thousand. Third party license, maintenance and professional services expenses for Q3 2026 were €41,085 thousand and for the nine months ended September 30, 2026 were €118,961 thousand. Travel, telecommunications, supplies, software and equipment expenses for Q3 2026 were €18,682 thousand and for the nine months ended September 30, 2026 were €56,056 thousand. Professional fees for Q3 2026 were €6,411 thousand and for the nine months ended September 30, 2026 were €22,536 thousand. Other, net expenses for Q3 2026 were €7,078 thousand and for the nine months ended September 30, 2026 were €23,641 thousand. Depreciation for Q3 2026 was €11,953 thousand and for the nine months ended September 30, 2026 was €35,326 thousand. Amortization of intangible assets for Q3 2026 was €47,791 thousand and for the nine months ended September 30, 2026 was €138,449 thousand. Net income attributable to equity holders of Topicus for Q3 2026 was €28,718 thousand and for the nine months ended September 30, 2026 was €93,066 thousand. Net income attributable to non-controlling interests for Q3 2026 was €17,795 thousand and for the nine months ended September 30, 2026 was €55,835 thousand. Weighted average basic shares outstanding for Q3 2026 were 83,702,570 and for the nine months ended September 30, 2026 were 83,485,101. Weighted average diluted shares outstanding for both periods were 129,841,819. Earnings per basic and diluted share for Q3 2026 were €0.34 and for the nine months ended September 30, 2026 were €1.11. Total comprehensive income for Q3 2026 was €48,423 thousand and for the nine months ended September 30, 2026 was €156,890 thousand. Total comprehensive income attributable to equity holders of Topicus for Q3 2026 was €30,096 thousand and for the nine months ended September 30, 2026 was €98,364 thousand. Total comprehensive income attributable to non-controlling interests for Q3 2026 was €18,327 thousand and for the nine months ended September 30, 2026 was €58,526 thousand.

Robin van Poelje to Retire as CEO of Topicus.com Inc. on October 1, 2026; Board Names Ramon Zanders as his Successor

(TSXV:TOI) Topicus.com Inc. announced that Robin van Poelje has decided to retire from his position as Chief Executive Officer of Topicus for personal reasons. Ramon Zanders, who is currently the Group CEO of the Total Specific Solutions Blue operating group within Topicus, has been appointed as the new Chief Executive Officer of Topicus by the Topicus Board of Directors. These executive changes will be effective October 1, 2026. After his retirement as Chief Executive Officer, Mr. van Poelje will remain with the company as a Director and Chairman of the Board of Topicus. The announcement provides no further details regarding compensation, severance, or additional board changes. The company has not disclosed any financial figures or operational updates in this release. The release does not mention any changes to the company's business strategy or operations as a result of these appointments.

Constellation Software Inc. and Topicus.com Inc. Announce Results for Topicus.com Inc. for the Second Quarter Ended June 30, 2026

(TSXV:TOI) Topicus.com Inc. announced financial results for the second quarter ended June 30, 2026, reporting revenue of €437.3 million, an increase of 18% compared to €372.0 million in Q2 2025. Net income increased 14% to €47.3 million (€0.36 on a diluted per share basis) from €41.5 million (€0.31 on a diluted per share basis) in Q2 2025. Acquisitions were completed for aggregate cash consideration of €31.2 million, with deferred payments valued at €9.0 million, resulting in total consideration of €40.2 million. Cash flows from operations were negative €12.7 million, an improvement from negative €14.9 million in Q2 2025. Free cash flow available to shareholders increased €31.3 million to €14.6 million compared to negative €16.7 million in Q2 2025. For the first six months of 2026, total revenues were €872.9 million, an increase of 20% compared to €727.6 million for the same period in 2025. The company experienced organic growth of 4% in Q2 2026 and 5% for the first six months of 2026.

The Oncology Institute Completes Strategic Refinancing with OrbiMed, Repaying the Outstanding $86 Million Deerfield Convertible Note, Strengthening its Balance Sheet, and Improving Liquidity

(NASDAQ: TOI) The Oncology Institute, Inc. announced that it has repaid its $86 Million senior secured convertible note with Deerfield Partners through a debt refinancing that includes new credit facilities from OrbiMed. Under the new financing arrangements with OrbiMed, TOI repaid the outstanding balance of its $86 million senior secured convertible note with a new $75 million term loan with OrbiMed maturing in 2031 as well as approximately $11 million of cash from the balance sheet without raising additional equity. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 2.0 million patients. The company has over 400 employed and network clinicians and over 100 clinics and network locations of care across five states. Founded in 2007, The Oncology Institute, Inc. is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. The company states that the transaction is intended to increase liquidity, improve operating flexibility and extend debt maturities. Management also claims that the transaction significantly extends debt maturities and establishes committed funding from two leading healthcare financing institutions.

Topicus.com Inc. Announces a Revised Proposal to Acquire ReadyTech

(TSXV: TOI) Topicus.com Inc., through its subsidiary TSS Europe B.V. (“TSS”), submitted a revised non-binding indicative proposal to acquire ReadyTech Holdings Limited (ASX: RDY) by way of a scheme of arrangement for cash consideration of $2.00 per share, or alternatively, an off-market takeover bid with a 50.1% minimum acceptance condition at a cash consideration of $1.75 per share. The Scheme Consideration of $2.00 per share represents a 49.3% premium to ReadyTech’s closing share price of $1.34 on May 29, 2026, a 47.5% premium to the one-month VWAP of $1.36, a 58.9% premium to the three-month VWAP of $1.26, and a 57.5% premium to the VWAP since 26 February, 2026. The Takeover Consideration of $1.75 per share represents a 30.6% premium to the closing share price of $1.34, a 29.1% premium to the one-month VWAP of $1.36, a 39.0% premium to the three-month VWAP of $1.26, and a 37.9% premium to the VWAP since 26 February, 2026. The Revised Proposal assumes the issued share capital of ReadyTech comprises 123,564,107 ordinary shares outstanding and 3,118,329 performance rights on issue as of 16 December 2025 remain unvested and lapse. The Revised Proposal is non-binding and subject to conditions including satisfactory confirmatory due diligence, positive recommendation of ReadyTech’s Board, approval of the Board of Directors of Topicus.com Inc., regulatory or government approvals, and execution of a Confidentiality Process and Exclusivity Deed. The company projects that the off-market takeover offer will be made simultaneously with the scheme of arrangement and would be conditional on the scheme not proceeding as a result of the scheme resolution failing to obtain the requisite approval of ReadyTech shareholders.

Constellation Software Inc. and Topicus.Com Inc. Announce Results for Topicus.com Inc. for the First Quarter Ended March 31, 2026

Topicus.com Inc. (TSXV:TOI), in a joint release with Constellation Software Inc. (TSX:CSU), announced its financial results for the first quarter ended March 31, 2026. Revenue increased 23% to €435.7 million compared to €355.6 million in Q1 2025, with 5% organic growth. Net income decreased to €55.1 million (€0.41 per diluted share) from €70.1 million (€0.54 per diluted share) in the prior year period. Acquisitions were completed for aggregate cash consideration of €15.0 million, with total consideration including deferred payments of €22.5 million. Cash flows from operations increased €9.0 million to €280.5 million, and free cash flow available to shareholders rose €3.7 million to €165.4 million.